Neuropeptide Y receptor antagonists

By Ling A.L.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 375-384

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptide Y receptor antagonists in obesity

By Gehlert D.R.   Hipskind P.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1827-1838

Informa Healthcare

Access to resources Recommend Favorite

Recent developments with neuropeptide Y receptor antagonists

By Lundberg J.M.   Modin A.   Malmstrom R.E.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 301-304

Elsevier

Access to resources Recommend Favorite

Effect of a selective neuropeptide Y Y 2 receptor antagonist, BIIE0246 on neuropeptide Y release

By King P.J.   Williams G.   Doods H.   Widdowson P.S.  

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Effects of the neuropeptide Y Y 2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices

By Weiser T.   Wieland H.A.   Doods H.N.  

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 133-136

Elsevier

Access to resources Recommend Favorite